Cadence Design Systems lifts 2026 revenue and profit outlook amid AI chip surge
Cadence Design Systems announced on Monday that it has raised its fiscal‑2026 revenue forecast to $6.26‑$6.34 billion, up from $6.13‑$6.23 billion, and its adjusted profit outlook to $8.05‑$8.15 per share, above previous guidance of $7.85‑$7.95. The company said the upgrades reflect sharply higher demand for its AI‑powered electronic‑design‑automation tools used by chipmakers and technology firms developing sophisticated systems‑on‑chip and AI accelerators. Major customers cited include Nvidia and Apple.
Quarter‑two results showed revenue of $1.584 billion, a 24.2% year‑over‑year increase, and earnings of $2.11 per share, both roughly in line with estimates. Cadence reported a backlog of $8.1 billion, with about $4.2 billion expected to be recognized as revenue within the next twelve months. Earlier in the month the firm introduced an AI “super‑agent” named AuraStack that lets engineers describe design goals in plain language and automates circuit‑layout and virtual testing. Shares rose more than 5% in extended trading.
Entities: Apple · AuraStack · Cadence Design Systems · Nvidia
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] Cadence's second‑quarter adjusted profit was $2.11 per share. (all articles)
- [● 3 SOURCES] Demand for Cadence's AI‑powered chip and system design software has risen sharply. (all articles)
- [● 3 SOURCES] Cadence's customers include Nvidia and Apple. (all articles)
- [● 3 SOURCES] Cadence launched an AI “super agent” called AuraStack earlier in the month. (all articles)
- [● 3 SOURCES] Cadence Design Systems raised its 2026 adjusted profit forecast to between $8.05 and $8.15 per share. (all articles)
- [● 3 SOURCES] Cadence Design Systems raised its 2026 revenue forecast to between $6.26 billion and $6.34 billion. (all articles)
- [● 3 SOURCES] Cadence's second‑quarter revenue rose 24.2% to $1.584 billion. (all articles)
- [● 3 SOURCES] Cadence's quarter‑end backlog stood at $8.1 billion, with $4.2 billion expected to be recognized as revenue within the next 12 months. (all articles)